Company
Pathos
Delivering the Next Generation of Biopharma
Also known as Pathos AI, Inc
- Business model
- B2B
- Legal name
- Pathos AI, Inc
Claim, correct or request removal
Record updated 28 October 2026
About
Pathos integrates AI technology, biological modeling, and the largest collection of oncology patient data to make clinical trials smarter and more precise.
Funding snapshot
- Total raised
- $365MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Series D+, $237M2026-10-24
Funding rounds
- Series D+
- $237M2026-10-24, Announced, post-money $3B
- Round, 2025
- $283M2025-04-17, SEC form D sold, 11 investors
- Round, 2024
- $62M2024-10-24, SEC form D sold, 13 investors
- Round, 2023
- $20M2023-02-17, SEC form D sold, 4 investors
Loading relationship preview